<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32887382</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>9</Issue><PubDate><Year>2020</Year><Month>Sep</Month><Day>02</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>A Simple Differentiation Protocol for Generation of Induced Pluripotent Stem Cell-Derived Basal Forebrain-Like Cholinergic Neurons for Alzheimer's Disease and Frontotemporal Dementia Disease Modeling.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2018</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells9092018</ELocationID><Abstract><AbstractText>The study of neurodegenerative diseases using pluripotent stem cells requires new methods to assess neurodevelopment and neurodegeneration of specific neuronal subtypes. The cholinergic system, characterized by its use of the neurotransmitter acetylcholine, is one of the first to degenerate in Alzheimer's disease and is also affected in frontotemporal dementia. We developed a differentiation protocol to generate basal forebrain-like cholinergic neurons (BFCNs) from induced pluripotent stem cells (iPSCs) aided by the use of small molecule inhibitors and growth factors. Ten iPSC lines were successfully differentiated into BFCNs using this protocol. The neuronal cultures were characterised through RNA and protein expression, and functional analysis of neurons was confirmed by whole-cell patch clamp. We have developed a reliable protocol using only small molecule inhibitors and growth factors, while avoiding transfection or cell sorting methods, to achieve a BFCN culture that expresses the characteristic markers of cholinergic neurons.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mu&#xf1;oz</LastName><ForeName>Sonia Sanz</ForeName><Initials>SS</Initials><Identifier Source="ORCID">0000-0003-0970-3637</Identifier><AffiliationInfo><Affiliation>Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Engel</LastName><ForeName>Martin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7602-1340</Identifier><AffiliationInfo><Affiliation>Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balez</LastName><ForeName>Rachelle</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-2787-7107</Identifier><AffiliationInfo><Affiliation>Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Do-Ha</LastName><ForeName>Dzung</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabral-da-Silva</LastName><ForeName>Mauricio Castro</ForeName><Initials>MC</Initials><Identifier Source="ORCID">0000-0002-3607-9158</Identifier><AffiliationInfo><Affiliation>Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hern&#xe1;ndez</LastName><ForeName>Damian</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anatomy &amp; Neuroscience, University of Melbourne, Parkville, VIC 3010, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, University of Melbourne, Parkville, VIC 3010, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Eye Research Australia, Royal Victoria Eye and Ear Hospital, Melbourne, VIC 3002, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berg</LastName><ForeName>Tracey</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fifita</LastName><ForeName>Jennifer A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Centre for Motor Neuron Disease Research, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW 2190, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grima</LastName><ForeName>Natalie</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-6434-7706</Identifier><AffiliationInfo><Affiliation>Centre for Motor Neuron Disease Research, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW 2190, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Shu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Motor Neuron Disease Research, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW 2190, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blair</LastName><ForeName>Ian P</ForeName><Initials>IP</Initials><AffiliationInfo><Affiliation>Centre for Motor Neuron Disease Research, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW 2190, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicholson</LastName><ForeName>Garth</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Concord Repatriation General Hospital, University of Sydney ANZAC Research Institute, Sydney, NSW 2006, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>Anthony L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Wicking Dementia Research and Education Centre, University of Tasmania, Hobart, TAS 7001, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hewitt</LastName><ForeName>Alex W</ForeName><Initials>AW</Initials><Identifier Source="ORCID">0000-0002-5123-5999</Identifier><AffiliationInfo><Affiliation>Department of Surgery, University of Melbourne, Parkville, VIC 3010, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Eye Research Australia, Royal Victoria Eye and Ear Hospital, Melbourne, VIC 3002, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS 7000, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;bay</LastName><ForeName>Alice</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7408-9453</Identifier><AffiliationInfo><Affiliation>Department of Anatomy &amp; Neuroscience, University of Melbourne, Parkville, VIC 3010, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, University of Melbourne, Parkville, VIC 3010, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Eye Research Australia, Royal Victoria Eye and Ear Hospital, Melbourne, VIC 3002, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ooi</LastName><ForeName>Lezanne</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-9241-8268</Identifier><AffiliationInfo><Affiliation>Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C459179">4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001549">Benzamides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019208">Brain-Derived Neurotrophic Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003470">Culture Media</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004149">Dioxoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C525887">GDF2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D055427">Growth Differentiation Factor 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053823">Hedgehog Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C554430">LDN 193189</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C502240">NGF protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011720">Pyrazoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C509239">SHH protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016212">Transforming Growth Factor beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>103107-01-3</RegistryNumber><NameOfSubstance UI="D016222">Fibroblast Growth Factor 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>7171WSG8A2</RegistryNumber><NameOfSubstance UI="C579455">BDNF protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>9061-61-4</RegistryNumber><NameOfSubstance UI="D020932">Nerve Growth Factor</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066187" MajorTopicYN="N">Basal Forebrain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001549" MajorTopicYN="N">Benzamides</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019208" MajorTopicYN="N">Brain-Derived Neurotrophic Factor</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059329" MajorTopicYN="N">Cholinergic Neurons</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003470" MajorTopicYN="N">Culture Media</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004149" MajorTopicYN="N">Dioxoles</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058732" MajorTopicYN="N">Embryoid Bodies</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016222" MajorTopicYN="N">Fibroblast Growth Factor 2</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055427" MajorTopicYN="N">Growth Differentiation Factor 2</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053823" MajorTopicYN="N">Hedgehog Proteins</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="N">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020932" MajorTopicYN="N">Nerve Growth Factor</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018408" MajorTopicYN="N">Patch-Clamp Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061251" MajorTopicYN="N">Primary Cell Culture</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011720" MajorTopicYN="N">Pyrazoles</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016212" MajorTopicYN="N">Transforming Growth Factor beta</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">cholinergic neurons</Keyword><Keyword MajorTopicYN="N">disease modelling</Keyword><Keyword MajorTopicYN="N">frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">induced pluripotent stem cells</Keyword><Keyword MajorTopicYN="N">neuronal differentiation</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>5</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32887382</ArticleId><ArticleId IdType="pmc">PMC7564334</ArticleId><ArticleId IdType="doi">10.3390/cells9092018</ArticleId><ArticleId IdType="pii">cells9092018</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mufson E.J., Counts S.E., Perez S.E., Ginsberg S.D. Cholinergic system during the progression of Alzheimer&#x2019;s disease: Therapeutic implications. Expert Rev. Neurother. 2008;8:1703&#x2013;1718. doi: 10.1586/14737175.8.11.1703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14737175.8.11.1703</ArticleId><ArticleId IdType="pmc">PMC2631573</ArticleId><ArticleId IdType="pubmed">18986241</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitehouse P.J., Price D.L., Struble R.G., Clark A.W., Coyle J.T., Delon M.R. Alzheimer&#x2019;s disease and senile dementia: Loss of neurons in the basal forebrain. Science. 1982;215:1237&#x2013;1239. doi: 10.1126/science.7058341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.7058341</ArticleId><ArticleId IdType="pubmed">7058341</ArticleId></ArticleIdList></Reference><Reference><Citation>Yiannopoulou K.G., Papageorgiou S.G. Current and future treatments for Alzheimer&#x2019;s disease. Adv. Neurol. Disord. 2013;6:19&#x2013;33. doi: 10.1177/1756285612461679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1756285612461679</ArticleId><ArticleId IdType="pmc">PMC3526946</ArticleId><ArticleId IdType="pubmed">23277790</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaeverbeke J., Evenepoel C., Bruffaerts R., Van Laere K., Bormans G., Dries E., Tousseyn T., Nelissen N., Peeters R., Vandenbulcke M., et al. Cholinergic depletion and basal forebrain volume in primary progressive aphasia. Neuroimage Clin. 2017;13:271&#x2013;279. doi: 10.1016/j.nicl.2016.11.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2016.11.027</ArticleId><ArticleId IdType="pmc">PMC5176031</ArticleId><ArticleId IdType="pubmed">28018854</ArticleId></ArticleIdList></Reference><Reference><Citation>Convery R.S., Neason M.R., Cash D.M., Cardoso M.J., Modat M., Ourselin S., Warren J.D., Rohrer J.D., Bocchetta M. Basal forebrain atrophy in frontotemporal dementia. Neuroimage Clin. 2020;26:102210. doi: 10.1016/j.nicl.2020.102210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2020.102210</ArticleId><ArticleId IdType="pmc">PMC7058403</ArticleId><ArticleId IdType="pubmed">32143137</ArticleId></ArticleIdList></Reference><Reference><Citation>St George-Hyslop P.H., Petit A. Molecular biology and genetics of Alzheimer&#x2019;s disease. C. R. Biol. 2005;328:119&#x2013;130. doi: 10.1016/j.crvi.2004.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.crvi.2004.10.013</ArticleId><ArticleId IdType="pubmed">15770998</ArticleId></ArticleIdList></Reference><Reference><Citation>Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer&#x2019;s disease in late onset families. Science. 1993;261:921&#x2013;923. doi: 10.1126/science.8346443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8346443</ArticleId><ArticleId IdType="pubmed">8346443</ArticleId></ArticleIdList></Reference><Reference><Citation>Saunders A.M., Strittmatter W.J., Schmechel D., George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., Alberts M.J. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer&#x2019;s disease. Neurology. 1993;43:1467&#x2013;1472. doi: 10.1212/WNL.43.8.1467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.43.8.1467</ArticleId><ArticleId IdType="pubmed">8350998</ArticleId></ArticleIdList></Reference><Reference><Citation>Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., Roses A.D. Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA. 1993;90:1977&#x2013;1981. doi: 10.1073/pnas.90.5.1977.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.90.5.1977</ArticleId><ArticleId IdType="pmc">PMC46003</ArticleId><ArticleId IdType="pubmed">8446617</ArticleId></ArticleIdList></Reference><Reference><Citation>Engel M., Do-Ha D., Mu&#xf1;oz S.S., Ooi L. Common pitfalls of stem cell differentiation: A guide to improving protocols for neurodegenerative disease models and research. Cell. Mol. Life Sci. 2016;73:3693&#x2013;3709. doi: 10.1007/s00018-016-2265-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-016-2265-3</ArticleId><ArticleId IdType="pmc">PMC5002043</ArticleId><ArticleId IdType="pubmed">27154043</ArticleId></ArticleIdList></Reference><Reference><Citation>Bissonnette C.J., Lyass L., Bhattacharyya B.J., Belmadani A., Miller R.J., Kessler J.A. The controlled generation of functional basal forebrain cholinergic neurons from human embryonic stem cells. Stem Cells. 2011;29:802&#x2013;811. doi: 10.1002/stem.626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.626</ArticleId><ArticleId IdType="pmc">PMC3107131</ArticleId><ArticleId IdType="pubmed">21381151</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno C.L., Della Guardia L., Shnyder V., Ortiz-Virumbrales M., Kruglikov I., Zhang B., Schadt E.E., Tanzi R.E., Noggle S., Buettner C., et al. iPSC-derived familial Alzheimer&#x2019;s PSEN2 N141I cholinergic neurons exhibit mutation-dependent molecular pathology corrected by insulin signaling. Mol. Neurodegener. 2018;13:33. doi: 10.1186/s13024-018-0265-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-018-0265-5</ArticleId><ArticleId IdType="pmc">PMC6020427</ArticleId><ArticleId IdType="pubmed">29945658</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortiz-Virumbrales M., Moreno C.L., Kruglikov I., Marazuela P., Sproul A., Jacob S., Zimmer M., Paull D., Zhang B., Schadt E.E., et al. CRISPR/Cas9-Correctable mutation-related molecular and physiological phenotypes in iPSC-derived Alzheimer&#x2019;s PSEN2 N141I neurons. Acta Neuropathol. Commun. 2017;5:77. doi: 10.1186/s40478-017-0475-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-017-0475-z</ArticleId><ArticleId IdType="pmc">PMC5660456</ArticleId><ArticleId IdType="pubmed">29078805</ArticleId></ArticleIdList></Reference><Reference><Citation>Balez R., Steiner N., Engel M., Mu&#xf1;oz S.S., Lum J.S., Wu Y., Wang D., Vallotton P., Sachdev P., O&#x2019;Connor M., et al. Neuroprotective effects of apigenin against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer&#x2019;s disease. Sci. Rep. 2016;6:31450. doi: 10.1038/srep31450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep31450</ArticleId><ArticleId IdType="pmc">PMC4981845</ArticleId><ArticleId IdType="pubmed">27514990</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu&#xf1;oz S.S., Balez R., Castro Cabral-da-Silva M.E., Berg T., Engel M., Bax M., Do-Ha D., Stevens C.H., Greenough M., Bush A., et al. Generation and characterization of human induced pluripotent stem cell lines from a familial Alzheimer&#x2019;s disease PSEN1 A246E patient and a non-demented family member bearing wild-type PSEN1. Stem Cell Res. 2018;31:227&#x2013;230. doi: 10.1016/j.scr.2018.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2018.08.006</ArticleId><ArticleId IdType="pubmed">30138848</ArticleId></ArticleIdList></Reference><Reference><Citation>Engel M., Balez R., Mu&#xf1;oz S.S., Cabral-da-Silva M.C., Stevens C.H., Bax M., Do-Ha D., Sidhu K., Sachdev P., Ooi L. Viral-free generation and characterization of a human induced pluripotent stem cell line from dermal fibroblasts. Stem Cell Res. 2018;32:135&#x2013;138. doi: 10.1016/j.scr.2018.09.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2018.09.014</ArticleId><ArticleId IdType="pubmed">30278375</ArticleId></ArticleIdList></Reference><Reference><Citation>Konttinen H., Cabral-da-Silva M.E.C., Ohtonen S., Wojciechowski S., Shakirzyanova A., Caligola S., Giugno R., Ishchenko Y., Hern&#xe1;ndez D., Fazaludeen M.F., et al. PSEN1&#x394;E9, APPswe, and APOE4 Confer Disparate Phenotypes in Human iPSC-Derived Microglia. Stem Cell Rep. 2019;13:669&#x2013;683. doi: 10.1016/j.stemcr.2019.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2019.08.004</ArticleId><ArticleId IdType="pmc">PMC6829767</ArticleId><ArticleId IdType="pubmed">31522977</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi L., Sidhu K., Poljak A., Sutherland G., O&#x2019;Connor M.D., Sachdev P., M&#xfc;nch G. Induced pluripotent stem cells as tools for disease modelling and drug discovery in Alzheimer&#x2019;s disease. J. Neural Transm. 2013;120:103&#x2013;111. doi: 10.1007/s00702-012-0839-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-012-0839-2</ArticleId><ArticleId IdType="pubmed">22695755</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X.-J., Zhang X., Johnson M.A., Wang Z.-B., Lavaute T., Zhang S.-C. Coordination of sonic hedgehog and Wnt signaling determines ventral and dorsal telencephalic neuron types from human embryonic stem cells. Development. 2009;136:4055&#x2013;4063. doi: 10.1242/dev.036624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.036624</ArticleId><ArticleId IdType="pmc">PMC2778748</ArticleId><ArticleId IdType="pubmed">19906872</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi H., Liu F.-C. Genetic patterning of the mammalian telencephalon by morphogenetic molecules and transcription factors. Birth Defects Res. C Embryo Today. 2006;78:256&#x2013;266. doi: 10.1002/bdrc.20077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bdrc.20077</ArticleId><ArticleId IdType="pubmed">17061260</ArticleId></ArticleIdList></Reference><Reference><Citation>Alderson R.F., Alterman A.L., Barde Y.A., Lindsay R.M. Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture. Neuron. 1990;5:297&#x2013;306. doi: 10.1016/0896-6273(90)90166-D.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(90)90166-D</ArticleId><ArticleId IdType="pubmed">2169269</ArticleId></ArticleIdList></Reference><Reference><Citation>Auld D.S., Mennicken F., Quirion R. Nerve growth factor rapidly induces prolonged acetylcholine release from cultured basal forebrain neurons: Differentiation between neuromodulatory and neurotrophic influences. J. Neurosci. 2001;21:3375&#x2013;3382. doi: 10.1523/JNEUROSCI.21-10-03375.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.21-10-03375.2001</ArticleId><ArticleId IdType="pmc">PMC6762468</ArticleId><ArticleId IdType="pubmed">11331367</ArticleId></ArticleIdList></Reference><Reference><Citation>Sofroniew M.V., Howe C.L., Mobley W.C. Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci. 2001;24:1217&#x2013;1281. doi: 10.1146/annurev.neuro.24.1.1217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.neuro.24.1.1217</ArticleId><ArticleId IdType="pubmed">11520933</ArticleId></ArticleIdList></Reference><Reference><Citation>van Laar J.A., Rustum Y.M., Ackland S.P., van Groeningen C.J., Peters G.J. Comparison of 5-fluoro-2&#x2019;-deoxyuridine with 5-fluorouracil and their role in the treatment of colorectal cancer. Eur. J. Cancer. 1998;34:296&#x2013;306. doi: 10.1016/S0959-8049(97)00366-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0959-8049(97)00366-3</ArticleId><ArticleId IdType="pubmed">9640213</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia Z., Wiebe L.I., Miller G.G., Knaus E.E. Synthesis and biological evaluation of butanoate, retinoate, and bis(2,2,2-trichloroethyl)phosphate derivatives of 5-fluoro-2&#x2019;-deoxyuridine and 2&#x2019;,5-difluoro-2&#x2019;-deoxyuridine as potential dual action anticancer prodrugs. Arch. Pharm. 1999;332:286&#x2013;294. doi: 10.1002/(SICI)1521-4184(19998)332:8&lt;286::AID-ARDP286&gt;3.0.CO;2-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1521-4184(19998)332:8&lt;286::AID-ARDP286&gt;3.0.CO;2-9</ArticleId><ArticleId IdType="pubmed">10489539</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulisano M., Broccoli V., Pardini C., Boncinelli E. Emx1 and Emx2 show different patterns of expression during proliferation and differentiation of the developing cerebral cortex in the mouse. Eur. J. Neurosci. 1996;8:1037&#x2013;1050. doi: 10.1111/j.1460-9568.1996.tb01590.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.1996.tb01590.x</ArticleId><ArticleId IdType="pubmed">8743751</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida M., Suda Y., Matsuo I., Miyamoto N., Takeda N., Kuratani S., Aizawa S. Emx1 and Emx2 functions in development of dorsal telencephalon. Development. 1997;124:101&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pubmed">9006071</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro D.S., Martynoga B., Parras C., Ramesh V., Pacary E., Johnston C., Drechsel D., Lebel-Potter M., Garcia L.G., Hunt C., et al. A novel function of the proneural factor Ascl1 in progenitor proliferation identified by genome-wide characterization of its targets. Genes Dev. 2011;25:930&#x2013;945. doi: 10.1101/gad.627811.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.627811</ArticleId><ArticleId IdType="pmc">PMC3084027</ArticleId><ArticleId IdType="pubmed">21536733</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross S.E., Greenberg M.E., Stiles C.D. Basic helix-loop-helix factors in cortical development. Neuron. 2003;39:13&#x2013;25. doi: 10.1016/S0896-6273(03)00365-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(03)00365-9</ArticleId><ArticleId IdType="pubmed">12848929</ArticleId></ArticleIdList></Reference><Reference><Citation>Poitras L., Ghanem N., Hatch G., Ekker M. The proneural determinant MASH1 regulates forebrain Dlx1/2 expression through the I12b intergenic enhancer. Development. 2007;134:1755&#x2013;1765. doi: 10.1242/dev.02845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.02845</ArticleId><ArticleId IdType="pubmed">17409112</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho H.-H., Cargnin F., Kim Y., Lee B., Kwon R.-J., Nam H., Shen R., Barnes A.P., Lee J.W., Lee S., et al. Isl1 directly controls a cholinergic neuronal identity in the developing forebrain and spinal cord by forming cell type-specific complexes. PLoS Genet. 2014;10:e1004280. doi: 10.1371/journal.pgen.1004280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1004280</ArticleId><ArticleId IdType="pmc">PMC3998908</ArticleId><ArticleId IdType="pubmed">24763339</ArticleId></ArticleIdList></Reference><Reference><Citation>Manuel M., Martynoga B., Yu T., West J.D., Mason J.O., Price D.J. The transcription factor Foxg1 regulates the competence of telencephalic cells to adopt subpallial fates in mice. Development. 2010;137:487&#x2013;497. doi: 10.1242/dev.039800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.039800</ArticleId><ArticleId IdType="pmc">PMC2858907</ArticleId><ArticleId IdType="pubmed">20081193</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Mar&#xed;n O., Hermesz E., Powell A., Flames N., Palkovits M., Rubenstein J.L.R., Westphal H. The LIM-homeobox gene Lhx8 is required for the development of many cholinergic neurons in the mouse forebrain. Proc. Natl. Acad. Sci. USA. 2003;100:9005&#x2013;9010. doi: 10.1073/pnas.1537759100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1537759100</ArticleId><ArticleId IdType="pmc">PMC166428</ArticleId><ArticleId IdType="pubmed">12855770</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomellini E., Lagadec C., Polakowska R., Le Bourhis X. Role of p75 neurotrophin receptor in stem cell biology: More than just a marker. Cell. Mol. Life Sci. 2014;71:2467&#x2013;2481. doi: 10.1007/s00018-014-1564-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-014-1564-9</ArticleId><ArticleId IdType="pubmed">24481864</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue W., Li Y., Zhang T., Jiang M., Qian Y., Zhang M., Sheng N., Feng S., Tang K., Yu X., et al. ESC-derived basal forebrain cholinergic neurons ameliorate the cognitive symptoms associated with Alzheimer&#x2019;s disease in mouse models. Stem Cell Rep. 2015;5:776&#x2013;790. doi: 10.1016/j.stemcr.2015.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2015.09.010</ArticleId><ArticleId IdType="pmc">PMC4649256</ArticleId><ArticleId IdType="pubmed">26489896</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y., Qu Z., Cao S., Li Q., Ma L., Krencik R., Xu M., Liu Y. Directed differentiation of basal forebrain cholinergic neurons from human pluripotent stem cells. J. Neurosci. Methods. 2016;266:42&#x2013;49. doi: 10.1016/j.jneumeth.2016.03.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneumeth.2016.03.017</ArticleId><ArticleId IdType="pubmed">27036311</ArticleId></ArticleIdList></Reference><Reference><Citation>Mertens J., Reid D., Lau S., Kim Y., Gage F.H. Aging in a dish: iPSC-derived and directly induced neurons for studying brain Aging and age-related neurodegenerative diseases. Annu. Rev. Genet. 2018;52:271&#x2013;293. doi: 10.1146/annurev-genet-120417-031534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-genet-120417-031534</ArticleId><ArticleId IdType="pmc">PMC6415910</ArticleId><ArticleId IdType="pubmed">30208291</ArticleId></ArticleIdList></Reference><Reference><Citation>Vera E., Bosco N., Studer L. Generating Late-Onset Human iPSC-Based Disease Models by Inducing Neuronal Age-Related Phenotypes through Telomerase Manipulation. Cell Rep. 2016;17:1184&#x2013;1192. doi: 10.1016/j.celrep.2016.09.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.09.062</ArticleId><ArticleId IdType="pmc">PMC5089807</ArticleId><ArticleId IdType="pubmed">27760320</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller J.D., Ganat Y.M., Kishinevsky S., Bowman R.L., Liu B., Tu E.Y., Mandal P.K., Vera E., Shim J., Kriks S., et al. Human iPSC-based modeling of late-onset disease via progerin-induced aging. Cell Stem Cell. 2013;13:691&#x2013;705. doi: 10.1016/j.stem.2013.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2013.11.006</ArticleId><ArticleId IdType="pmc">PMC4153390</ArticleId><ArticleId IdType="pubmed">24315443</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiraboschi P., Hansen L.A., Alford M., Merdes A., Masliah E., Thal L.J., Corey-Bloom J. Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease. Arch. Gen. Psychiatry. 2002;59:946&#x2013;951. doi: 10.1001/archpsyc.59.10.946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpsyc.59.10.946</ArticleId><ArticleId IdType="pubmed">12365882</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>